Capstan Therapeutics' Laura Shawver on 'decorating' LNPs with antibodies
- blonca9
- Nov 3, 2023
- 1 min read
Updated: Nov 3, 2023
Dr. Shawver describes how Capstan plans to achieve in-vivo CAR-T by utilizing LNPs to deliver mRNA to lymphocytes in the body.